• Info
  • Insider Trading

Keith Katkin - Insider Trading & Ownership

Location
C/O Urovant Sciences, Inc., 5281 California Avenue, Suite 100, Irvine, CA
Summary
The estimated net worth of Keith Katkin is at least $1.5M dollars as of May 28, 2025. Keith Katkin is the Director of Syndax Pharmaceuticals Inc and owns shares of Syndax Pharmaceuticals Inc (SNDX) stock worth about $911K. Keith Katkin is the Director of Emergent BioSolutions Inc. and owns shares of Emergent BioSolutions Inc. (EBS) stock worth about $545K. Keith Katkin is the Director of RIGEL PHARMACEUTICALS INC and owns shares of RIGEL PHARMACEUTICALS INC (RIGL) stock worth about $43.8K.
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
All Insider Reports
All Insider Reports

Notify me when Keith Katkin files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Keith Katkin

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SNDX Syndax Pharmaceuticals Inc Director $911K +$91.1K +11.1% May 19, 2025
EBS Emergent BioSolutions Inc. Director $545K -$49.4K -8.32% May 23, 2025
RIGL RIGEL PHARMACEUTICALS INC Director $43.8K May 19, 2021
ELDN Eledon Pharmaceuticals, Inc. Director Jan 10, 2025

Insider Transactions Reported by Keith Katkin:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.